Dr. Reddy's recalls 4mg Tizanidine tablets due to shaved tablets that may cause improper dosing. Affected lots from India, expiring 09/2023.
Failed Tablet/Capsule Specification: Some tablets are shaved
Dr. Reddy's is recalling 4mg Tizanidine HCl tablets that may have shaved edges, which could lead to incorrect dosing. This is a medication safety issue for people using prescription doses.
Shaved tablet edges could cause improper dosing when taken. This might lead to incorrect medication amounts if the tablets are not measured properly.
Prescription users of Tizanidine HCl tablets in India. Those with the specific lot number T2000471 are most at risk.
Check for the lot number T2000471 on the bottle. The product was manufactured in Srikakulam, India, and expires September 2023.
Look for the lot number T2000471 on the bottle label.
The tablets may have shaved edges, which could lead to incorrect dosing.
Check for the lot number T2000471 on the bottle label.
The recall does not specify a remedy, so contact Dr. Reddy's for guidance.
We’ve drafted a message you can send Dr. Reddy's to request your refund or repair — edit it as you like.
Subject: Recall D-0750-2021 — Dr. Reddy's Dr. Reddy's Hello, I own a Dr. Reddy's that is covered by recall D-0750-2021 from Dr. Reddy's. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
